Snapshot
The global Human Cytomegalovirus Envelope Glycoprotein B market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Human Cytomegalovirus Envelope Glycoprotein B by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
CSJ-148
CyMVectin
TRL-345
PPCM
Cytomegalovirus Vaccine
Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Astellas Pharma Inc.
Trellis Bioscience, Inc.
Vakzine Projekt Management GmbH
VBI Vaccine Inc
Vical Incorporated
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Infectious Disease
Oncology
Women's Health
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
1 Industry Overview
1.1 Human Cytomegalovirus Envelope Glycoprotein B Industry
Figure Human Cytomegalovirus Envelope Glycoprotein B Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Human Cytomegalovirus Envelope Glycoprotein B
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Human Cytomegalovirus Envelope Glycoprotein B
1.2.2 Downstream
Table Application Segment of Human Cytomegalovirus Envelope Glycoprotein B
Table Global Human Cytomegalovirus Envelope Glycoprotein B Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Human Cytomegalovirus Envelope Glycoprotein B Market by Type
3.1 By Type
3.1.1 CSJ-148
Table Major Company List of CSJ-148
3.1.2 CyMVectin
Table Major Company List of CyMVectin
3.1.3 TRL-345
Table Major Company List of TRL-345
3.1.4 PPCM
Table Major Company List of PPCM
3.1.5 Cytomegalovirus Vaccine
Table Major Company List of Cytomegalovirus Vaccine
3.1.6 Others
Table Major Company List of Others
3.2 Market Size
Table Global Human Cytomegalovirus Envelope Glycoprotein B Market 2016-2020, by Type, in USD Million
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Market Growth 2016-2020, by Type, in USD Million
Table Global Human Cytomegalovirus Envelope Glycoprotein B Market 2016-2020, by Type, in Volume
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Human Cytomegalovirus Envelope Glycoprotein B Market Forecast 2021-2026, by Type, in USD Million
Table Global Human Cytomegalovirus Envelope Glycoprotein B Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Astellas Pharma Inc. (Company Profile, Sales Data etc.)
4.1.1 Astellas Pharma Inc. Profile
Table Astellas Pharma Inc. Overview List
4.1.2 Astellas Pharma Inc. Products & Services
4.1.3 Astellas Pharma Inc. Business Operation Conditions
Table Business Operation of Astellas Pharma Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Trellis Bioscience, Inc. (Company Profile, Sales Data etc.)
4.2.1 Trellis Bioscience, Inc. Profile
Table Trellis Bioscience, Inc. Overview List
4.2.2 Trellis Bioscience, Inc. Products & Services
4.2.3 Trellis Bioscience, Inc. Business Operation Conditions
Table Business Operation of Trellis Bioscience, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Vakzine Projekt Management GmbH (Company Profile, Sales Data etc.)
4.3.1 Vakzine Projekt Management GmbH Profile
Table Vakzine Projekt Management GmbH Overview List
4.3.2 Vakzine Projekt Management GmbH Products & Services
4.3.3 Vakzine Projekt Management GmbH Business Operation Conditions
Table Business Operation of Vakzine Projekt Management GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 VBI Vaccine Inc (Company Profile, Sales Data etc.)
4.4.1 VBI Vaccine Inc Profile
Table VBI Vaccine Inc Overview List
4.4.2 VBI Vaccine Inc Products & Services
4.4.3 VBI Vaccine Inc Business Operation Conditions
Table Business Operation of VBI Vaccine Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Vical Incorporated (Company Profile, Sales Data etc.)
4.5.1 Vical Incorporated Profile
Table Vical Incorporated Overview List
4.5.2 Vical Incorporated Products & Services
4.5.3 Vical Incorporated Business Operation Conditions
Table Business Operation of Vical Incorporated (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Human Cytomegalovirus Envelope Glycoprotein B Sales Revenue 2016-2020, by Company, in USD Million
Table Global Human Cytomegalovirus Envelope Glycoprotein B Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Sales Revenue Share in 2020, by Company, in USD Million
Table Global Human Cytomegalovirus Envelope Glycoprotein B Sales Volume 2016-2020, by Company, in Volume
Table Global Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Human Cytomegalovirus Envelope Glycoprotein B Market Concentration, in 2020
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Market Market Concentration, in 2020
Figure Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B MMarket Concentration, in 2020
Figure South America Human Cytomegalovirus Envelope Glycoprotein B Market Concentration, in 2020
Figure Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Infectious Disease
Figure Human Cytomegalovirus Envelope Glycoprotein B Demand in Infectious Disease, 2016-2020, in USD Million
Figure Human Cytomegalovirus Envelope Glycoprotein B Demand in Infectious Disease, 2016-2020, in Volume
6.1.2 Demand in Oncology
Figure Human Cytomegalovirus Envelope Glycoprotein B Demand in Oncology, 2016-2020, in USD Million
Figure Human Cytomegalovirus Envelope Glycoprotein B Demand in Oncology, 2016-2020, in Volume
6.1.3 Demand in Women's Health
Figure Human Cytomegalovirus Envelope Glycoprotein B Demand in Women's Health, 2016-2020, in USD Million
Figure Human Cytomegalovirus Envelope Glycoprotein B Demand in Women's Health, 2016-2020, in Volume
6.1.4 Demand in Others
Figure Human Cytomegalovirus Envelope Glycoprotein B Demand in Others, 2016-2020, in USD Million
Figure Human Cytomegalovirus Envelope Glycoprotein B Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Human Cytomegalovirus Envelope Glycoprotein B Demand Forecast 2021-2026, by Application, in USD Million
Figure Human Cytomegalovirus Envelope Glycoprotein B Market Growth 2021-2026, by Application, in USD Million
Figure Human Cytomegalovirus Envelope Glycoprotein B Market Share in 2026, by Application, in USD Million
Table Human Cytomegalovirus Envelope Glycoprotein B Demand Forecast 2021-2026, by Application, in Volume
Table Human Cytomegalovirus Envelope Glycoprotein B Market Growth 2021-2026, by Application, in Volume
Table Human Cytomegalovirus Envelope Glycoprotein B Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Human Cytomegalovirus Envelope Glycoprotein B Production 2016-2020, by Region, in USD Million
Table Human Cytomegalovirus Envelope Glycoprotein B Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Human Cytomegalovirus Envelope Glycoprotein B Market 2016-2020, by Region, in USD Million
Table Global Human Cytomegalovirus Envelope Glycoprotein B Market Share 2016-2020, by Region, in USD Million
Table Global Human Cytomegalovirus Envelope Glycoprotein B Market 2016-2020, by Region, in Volume
Table Global Human Cytomegalovirus Envelope Glycoprotein B Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth 2016-2020, in USD Million
Figure North America Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Human Cytomegalovirus Envelope Glycoprotein B Market Size 2016-2020, by Country, in USD Million
Table North America Human Cytomegalovirus Envelope Glycoprotein B Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth 2016-2020, in USD Million
Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size 2016-2020, by Country, in USD Million
Table Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth 2016-2020, in USD Million
Figure South America Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Human Cytomegalovirus Envelope Glycoprotein B Market Size 2016-2020, by Country, in USD Million
Table South America Human Cytomegalovirus Envelope Glycoprotein B Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Human Cytomegalovirus Envelope Glycoprotein B Market Forecast 2021-2026, by Region, in USD Million
Table Human Cytomegalovirus Envelope Glycoprotein B Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
List of Table
1. Table Upstream Segment of Human Cytomegalovirus Envelope Glycoprotein B
2. Table Application Segment of Human Cytomegalovirus Envelope Glycoprotein B
3. Table Global Human Cytomegalovirus Envelope Glycoprotein B Market 2016-2026, by Application, in USD Million
4. Table Major Company List of CyMVectin
5. Table Major Company List of TRL-345
6. Table Major Company List of PPCM
7. Table Major Company List of Cytomegalovirus Vaccine
8. Table Major Company List of Others
9. Table Global Human Cytomegalovirus Envelope Glycoprotein B Market 2016-2020, by Type, in USD Million
10. Table Global Human Cytomegalovirus Envelope Glycoprotein B Market 2016-2020, by Type, in Volume
11. Table Global Human Cytomegalovirus Envelope Glycoprotein B Market Forecast 2021-2026, by Type, in USD Million
12. Table Global Human Cytomegalovirus Envelope Glycoprotein B Market Forecast 2021-2026, by Type, in Volume
13. Table Astellas Pharma Inc. Overview List
14. Table Business Operation of Astellas Pharma Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
15. Table Trellis Bioscience, Inc. Overview List
16. Table Business Operation of Trellis Bioscience, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
17. Table Vakzine Projekt Management GmbH Overview List
18. Table Business Operation of Vakzine Projekt Management GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
19. Table VBI Vaccine Inc Overview List
20. Table Business Operation of VBI Vaccine Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
21. Table Vical Incorporated Overview List
22. Table Business Operation of Vical Incorporated (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
23. Table Global Human Cytomegalovirus Envelope Glycoprotein B Sales Revenue 2016-2020, by Company, in USD Million
24. Table Global Human Cytomegalovirus Envelope Glycoprotein B Sales Revenue Share 2016-2020, by Company, in USD Million
25. Table Global Human Cytomegalovirus Envelope Glycoprotein B Sales Volume 2016-2020, by Company, in Volume
26. Table Global Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Share 2016-2020, by Company, in Volume
27. Table Regional Demand Comparison List
28. Table Major Application in Different Regions
29. Table Human Cytomegalovirus Envelope Glycoprotein B Demand Forecast 2021-2026, by Application, in USD Million
30. Table Human Cytomegalovirus Envelope Glycoprotein B Demand Forecast 2021-2026, by Application, in Volume
31. Table Human Cytomegalovirus Envelope Glycoprotein B Market Growth 2021-2026, by Application, in Volume
32. Table Human Cytomegalovirus Envelope Glycoprotein B Market Share in 2026, by Application, in Volume
33. Table Human Cytomegalovirus Envelope Glycoprotein B Production 2016-2020, by Region, in USD Million
34. Table Human Cytomegalovirus Envelope Glycoprotein B Production 2016-2020, by Region, in Volume
35. Table Global Human Cytomegalovirus Envelope Glycoprotein B Market 2016-2020, by Region, in USD Million
36. Table Global Human Cytomegalovirus Envelope Glycoprotein B Market Share 2016-2020, by Region, in USD Million
37. Table Global Human Cytomegalovirus Envelope Glycoprotein B Market 2016-2020, by Region, in Volume
38. Table Global Human Cytomegalovirus Envelope Glycoprotein B Market Share 2016-2020, by Region, in Volume
39. Table North America Human Cytomegalovirus Envelope Glycoprotein B Market Size 2016-2020, by Country, in USD Million
40. Table North America Human Cytomegalovirus Envelope Glycoprotein B Market Size 2016-2020, by Country, in Volume
41. Table Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size 2016-2020, by Country, in USD Million
42. Table Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size 2016-2020, by Country, in Volume
43. Table Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size 2016-2020, by Country, in USD Million
44. Table Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size 2016-2020, by Country, in Volume
45. Table South America Human Cytomegalovirus Envelope Glycoprotein B Market Size 2016-2020, by Country, in USD Million
46. Table South America Human Cytomegalovirus Envelope Glycoprotein B Market Size 2016-2020, by Country, in Volume
47. Table Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size 2016-2020, by Country, in USD Million
48. Table Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size 2016-2020, by Country, in Volume
49. Table Human Cytomegalovirus Envelope Glycoprotein B Market Forecast 2021-2026, by Region, in USD Million
50. Table Human Cytomegalovirus Envelope Glycoprotein B Market Forecast 2021-2026, by Region, in Volume
51. Table Price Factors List
List of Figure
1. Figure Human Cytomegalovirus Envelope Glycoprotein B Industry Chain Structure
2. Figure Global Human Cytomegalovirus Envelope Glycoprotein B Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Human Cytomegalovirus Envelope Glycoprotein B Market Growth 2016-2020, by Type, in Volume
4. Figure Global Human Cytomegalovirus Envelope Glycoprotein B Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Human Cytomegalovirus Envelope Glycoprotein B Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Human Cytomegalovirus Envelope Glycoprotein B Market Concentration, in 2020
7. Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Market Market Concentration, in 2020
8. Figure Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B MMarket Concentration, in 2020
9. Figure South America Human Cytomegalovirus Envelope Glycoprotein B Market Concentration, in 2020
10. Figure Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Market Concentration, in 2020
11. Figure Human Cytomegalovirus Envelope Glycoprotein B Demand in Infectious Disease, 2016-2020, in USD Million
12. Figure Human Cytomegalovirus Envelope Glycoprotein B Demand in Infectious Disease, 2016-2020, in Volume
13. Figure Human Cytomegalovirus Envelope Glycoprotein B Demand in Oncology, 2016-2020, in USD Million
14. Figure Human Cytomegalovirus Envelope Glycoprotein B Demand in Oncology, 2016-2020, in Volume
15. Figure Human Cytomegalovirus Envelope Glycoprotein B Demand in Women's Health, 2016-2020, in USD Million
16. Figure Human Cytomegalovirus Envelope Glycoprotein B Demand in Women's Health, 2016-2020, in Volume
17. Figure Human Cytomegalovirus Envelope Glycoprotein B Demand in Others, 2016-2020, in USD Million
18. Figure Human Cytomegalovirus Envelope Glycoprotein B Demand in Others, 2016-2020, in Volume
19. Figure Human Cytomegalovirus Envelope Glycoprotein B Market Growth 2021-2026, by Application, in USD Million
20. Figure Human Cytomegalovirus Envelope Glycoprotein B Market Share in 2026, by Application, in USD Million
21. Figure North America Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth 2016-2020, in USD Million
22. Figure North America Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth 2016-2020, in Volume
23. Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth 2016-2020, in USD Million
24. Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth 2016-2020, in Volume
25. Figure Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth 2016-2020, in USD Million
26. Figure Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth 2016-2020, in Volume
27. Figure South America Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth 2016-2020, in USD Million
28. Figure South America Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth 2016-2020, in Volume
29. Figure Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth 2016-2020, in USD Million
30. Figure Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth 2016-2020, in Volume
31. Figure Marketing Channels Overview
| Price : US$ 3500 |
Date : Mar 2024 |
| Category : Electronics |
Pages : 129 |
Request Sample 
Request Discount 
Inquire Before Buy
